Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mankind Pharma has informed about proposed schedule of participation in Investor Conference by officials of the Company on November 18, 2025. The intimation of participation in the Investor Conference is also being uploaded on the website of the company i.e. www.mankindpharma.com.
The above information is a part of company’s filings submitted to BSE.
